Journal article · 2025 · Open access

Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra

Noelia Vera-Punzano, Ana Navascués, L. Armendáriz, Natividad Viguria, Mercedes Herranz-Aguirre, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín, Aitziber Echeverría, Iván Martínez‐Baz, Carmen Ezpeleta, Guillermo Ezpeleta, Jesús Castilla

Anales del Sistema Sanitario de Navarra, 48(2), e1133 · Published 29 August 2025 · DOI 10.23938/assn.1133

Open PDFView at the publisherCite this paper

In brief

“Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra” is a 2025 journal article by Noelia Vera-Punzano and 11 co-authors, published in Anales del Sistema Sanitario de Navarra. OpenAlex counts 2 citations as of 18 November 2026, which puts it in the top 5% of works published in 2025 by citations. It is open access under a CC BY-SA licence: the full text is free to read at Anales del Sistema Sanitario de Navarra.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
1.09
References
22
Authors
12

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of infant hospitalisation. In 2022, nirsevimab was approved in the European Union to prevent severe respiratory disease due to RSV during the first year of life. Our aim is to evaluate the effectiveness of nirsevimab immunoprophylaxis in new-borns for preventing RSV -related hospitalisations in Navarre, Spain, during its first two seasons of use. METHODS: Nirsevimab was offered free of charge to infants born from October to December 2023 and from September to December 2024. Each cohort was followed until February of the following year. Cases were infants hospitalised for PCR-confirmed RSV infection. Cox regression was used to estimate the hazard ratio of hospitalisation for immunised versus non-immunised children. RESULTS: Nirsevimab was offered to 2,699 new-borns; of them, 2,541 (94.1%) received nirsevimab. In the 2023-2024 season, 17 RSV-related hospitalisations were recorded and 24 in the 2024-2025 season. The average risk of RSV hospitalisation was 7.6% in non-immunised new-borns versus 1.1% in immunised ones. Overall, effectiveness of nirsevimab was 79.5% (95% CI: 59.2 - 89.7), with estimates of 89.9% in 2023-2024 and 52.8% in 2024-2025, with no significant differences between seasons (p=0.055). On average, one RSV hospitalisation was prevented per 22.6 immunised infants. CONCLUSIONS: Nirsevimab immunoprophylaxis substantially reduces RSV hospitalisations, helping ease paediatric hospital burden. However, as some immunised infants were still hospitalised, additional preventive measures remain necessary.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Vera-Punzano, N., Navascués, A., Armendáriz, L., Viguria, N., Herranz-Aguirre, M., Cenoz, M. G., Trobajo‐Sanmartín, C., Echeverría, A., Martínez‐Baz, I., Ezpeleta, C., Ezpeleta, G., & Castilla, J. (2025). Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra. Anales del Sistema Sanitario de Navarra, 48(2), e1133. https://doi.org/10.23938/assn.1133

MLA 9

Vera-Punzano, Noelia, et al. “Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra.” Anales del Sistema Sanitario de Navarra, vol. 48, no. 2, 2025, p. e1133. https://doi.org/10.23938/assn.1133.

Chicago

Vera-Punzano, Noelia, Ana Navascués, L. Armendáriz, Natividad Viguria, Mercedes Herranz-Aguirre, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín, et al. 2025. “Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra.” Anales del Sistema Sanitario de Navarra 48 (2): e1133. https://doi.org/10.23938/assn.1133.

Harvard

Vera-Punzano, N. et al. (2025) ‘Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra’, Anales del Sistema Sanitario de Navarra, 48(2), p. e1133. doi:10.23938/assn.1133.

IEEE

N. Vera-Punzano et al., “Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra,” Anales del Sistema Sanitario de Navarra, vol. 48, no. 2, p. e1133, 2025, doi: 10.23938/assn.1133.

BibTeX

@article{verapunzano2025efectividad,
  title     = {{Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra}},
  author    = {Vera-Punzano, Noelia and Navascués, Ana and Armendáriz, L. and Viguria, Natividad and Herranz-Aguirre, Mercedes and Cenoz, Manuel Garcìa and Trobajo‐Sanmartín, Camino and Echeverría, Aitziber and Martínez‐Baz, Iván and Ezpeleta, Carmen and Ezpeleta, Guillermo and Castilla, Jesús},
  journal   = {Anales del Sistema Sanitario de Navarra},
  year      = {2025},
  volume    = {48},
  number    = {2},
  pages     = {e1133},
  doi       = {10.23938/assn.1133},
  url       = {https://doi.org/10.23938/assn.1133}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Epidemiology › Respiratory viral infections research

  • nirsevimab
  • respiratory syncytial virus
  • RSV hospitalization
  • neonatal immunoprophylaxis
  • monoclonal antibodies
  • Navarre

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Vera-Punzano, N., Navascués, A., Armendáriz, L., Viguria, N., Herranz-Aguirre, M., Cenoz, M. G., Trobajo‐Sanmartín, C., Echeverría, A., Martínez‐Baz, I., Ezpeleta, C., Ezpeleta, G., & Castilla, J. (2025). Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra. Anales del Sistema Sanitario de Navarra, 48(2), e1133. https://doi.org/10.23938/assn.1133

How many times has this paper been cited?

2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Anales del Sistema Sanitario de Navarra: sign in and open the PDF from this page.

Who wrote this paper?

Noelia Vera-Punzano, Ana Navascués, L. Armendáriz, Natividad Viguria, Mercedes Herranz-Aguirre, Manuel Garcìa Cenoz, Camino Trobajo‐Sanmartín, Aitziber Echeverría, Iván Martínez‐Baz, Carmen Ezpeleta, Guillermo Ezpeleta, Jesús Castilla.

What is the DOI of this paper?

10.23938/assn.1133, permanently at https://doi.org/10.23938/assn.1133. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.